PTPRC and central nervous system cancer: Badie and Schartner were the first to use the discrimination of microglia and macrophages by their CD45 expression level in various models of rat glioma, where allogeneic and syngeneic tumor cell grafts, such as C6, 9L and RG-2, were used [64].